返回
Burning Rock Biotech Ltd (BNR) 收益
BNR 股價走勢圖
BNR 收益
Burning Rock Biotech Ltd
$16.2
-0.61%
$-0.1
收盤價：Apr 02, 16:00:00 GMT-4
$16.2
0%
$0
盤後：Apr 02, 20:00:00 GMT-4
最新獲利結果： Q3 '22
報導： 2022-11-15
歷史收益
每季
年度
EPS
收入
Earnings FAQ
BNR 最近的每股盈餘與預期相比如何？
Burning Rock Biotech Ltd BNR 上一季度的收入表現如何？
Burning Rock Biotech Ltd 的收入預期是多少？
Burning Rock Biotech Ltd 的盈利品質評分是多少？
Burning Rock Biotech Ltd 何時發布財報？
Burning Rock Biotech Ltd 的預期收益是多少？
Burning Rock Biotech Ltd 是否超出收益預期？
關鍵數據
前收市價
$16.3
開盤價
$16.79
當日範圍
$16.2 - $17.05
52週區間
$2.18 - $41.72
交易量
55.9K
平均成交量
28.8K
股息收益率
--
每股盈餘 (TTM)
-1.16
市值
$166.1M
什麼是 BNR？
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.